Departamento de Medicina Interna-Centro de Excelencia CIGES, Universidad de La Frontera, Temuco, Chile (Drs Seron and Lanas and Ms Velásquez); Departamento de Medicina Interna, Universidad de La Frontera, Temuco, Chile (Mss Gaete and Oliveros); Complejo Hospitalario San José, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile (Ms Román); Facultad de Ciencias Jurídicas y Empresariales, Centro de Excelencia CIGES, Universidad de La Frontera, Temuco, Chile (Dr Reveco); Departamento de Salud Pública, Centro de Excelencia CIGES, Universidad de La Frontera, Temuco, Chile (Mr Bustos); and Unidad de Evaluación de Tecnologías Sanitarias, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile (Mr Rojas).
J Cardiopulm Rehabil Prev. 2019 May;39(3):168-174. doi: 10.1097/HCR.0000000000000356.
To assess the cost-effectiveness of 3 models of exercise-based cardiac rehabilitation (CR) compared with standard care in survivors of acute coronary syndrome (ACS) within the public health system in Chile.
A Markov model was designed using 5 health states: ACS survivor, second ACS, complications, general mortality, and cardiovascular mortality. The transition probabilities between health states for standard care and corresponding relative risk for CR were calculated from a systematic review. Health benefits were measured with the EuroQol 5-dimensional 3-level (EQ-5D-3L) survey. Costs for each health state were quantified using the national cost verification study. The CR cost was estimated with a microcosting methodology. The time horizon was a lifetime and the discount rate was 3% per year for costs and benefits. Deterministic and probabilistic analyses were performed. Structural uncertainty was managed by designing 3 scenarios: CR as currently delivered in a specific Chilean public health center, CR as recommended by South American guidelines, and CR as proposed for low-resource settings.
Cardiac rehabilitation versus standard care showed an incremental cost-effectiveness ratio for the standard model of $722, for the South American model of $1247, and for the low-resource model of $666. The tornado diagram showed higher uncertainty in relative risk for the complications state and for the second ACS state.
Considering a cost-effectiveness threshold of 1 unit of gross domestic product per capita (∼$19 000), CR is highly cost-effective for the public health system in Chile.
在智利公共卫生系统中,评估 3 种基于运动的心脏康复(CR)模式与标准护理相比在急性冠脉综合征(ACS)幸存者中的成本效益。
使用 5 种健康状态设计了一个马尔可夫模型:ACS 幸存者、第二次 ACS、并发症、一般死亡率和心血管死亡率。标准护理和相应的 CR 相对风险的健康状态之间的转移概率是从系统评价中计算得出的。使用欧洲五维健康量表 3 级(EQ-5D-3L)调查衡量健康效益。使用国家成本验证研究量化每个健康状态的成本。CR 成本采用微观成本核算方法估算。时间范围为终生,成本和效益的贴现率为每年 3%。进行了确定性和概率分析。通过设计 3 种情景来管理结构不确定性:在特定的智利公共卫生中心目前提供的 CR、符合南美指南建议的 CR 以及为资源匮乏环境提出的 CR。
与标准护理相比,心脏康复的标准模型增量成本效益比为 722 美元,南美模型为 1247 美元,资源匮乏模型为 666 美元。在龙卷风图中,并发症状态和第二次 ACS 状态的相对风险的不确定性更高。
考虑到人均国内生产总值(约 19000 美元)的成本效益阈值,CR 在智利公共卫生系统中具有高度成本效益。